The trademark application TRODELVY was filed by Immunomedics, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on February 21, 2022, and it was registered by office on May 31, 2022 without any oppositions.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 5 with Pharmaceutical preparations for the treatment of oncological disorders, autoimmune disorders, inflammatory disorders and hematological disorders.
The mark was filed in class 44 with Providing medical information and advisory services regarding cancer.